Ads
related to: gw pharmaceuticals- Careers
Join our Mission to Improve
the Lives of Patients.
- Pipeline
Review our Pipeline and
See How We're Changing Treatment.
- Approved Medicines
See the Approved Treatments
Using Our Antibody Science.
- Sign Up
Sign Up for Updates, News
and Much More.
- Careers
Search results
Jazz's (JAZZ) Q2 Earnings Beat, New Drugs Post Robust Sales
Zacks via Yahoo Finance· 2 years agoJAZZ's Q2 earnings and sales beat expectations on strong demand for its new drugs and drugs added...
My Top Cannabis Stock to Buy in 2023 and Hold For 10 Years
Motley Fool· 1 year agoA few years ago, the cannabis industry attracted much interest from investors following significant...
Why Is Jazz (JAZZ) Up 0.1% Since Last Earnings Report?
Zacks via Yahoo Finance· 1 year agoA month has gone by since the last earnings report for Jazz Pharmaceuticals (JAZZ). Shares have...
Aurinia Pharmaceuticals Skids With Its Buyout Thesis Hanging By A Thread
Investor's Business Daily· 2 years agoAurinia Pharmaceuticals hired a trio of executives in a move that suggests it's nowhere near a...
JAZZ's Late-Stage Multiple Sclerosis Study on Nabiximols Fails
Zacks via Yahoo Finance· 2 years agoJAZZ's phase III study evaluating nabiximols oromucosal spray for clinical measures of spasticity in...
2 Dirt Cheap Growth Stocks to Buy and Hold for Years
Motley Fool· 2 years agoBuying stocks right now can seem like a bad idea given that the stock market isn't on firm footing, with the S&P 500 down 16% this year. A couple of...
Karuna, Cerevel might be just the start of psychiatry drug M&A
BioPharma Dive via Yahoo Finance· 4 months agoAbbVie and Bristol Myers Squibb each capped last year with multibillion-dollar acquisitions of...
3 Top Pot Stocks to Watch in September
Motley Fool· 2 years agoCannabis investors who have heard the siren call of how much growth is expected in the industry may be getting a little frustrated this year, with the...
Jazz Pharmaceuticals PLC (JAZZ) Reports Strong Revenue Growth and Robust Pipeline Progress
GuruFocus.com via Yahoo Finance· 3 months agoTotal Revenues: $3.8 billion in 2023, with a 27% year-over-year increase from key growth drivers....
Prediction: These Could Be the Best-Performing Cannabis Stocks Through 2030
Motley Fool· 9 months agoAfter Canada legalized adult uses of cannabis in 2018, investors rushed to invest in pot companies,...
